BACKGROUND AND AIMS: Smoking tobacco has opposite effects on the different forms of inflammatory bowel disease (IBD). It predisposes to the development of Crohn's disease (CD) yet is associated with a reduced incidence of ulcerative colitis (UC). We have studied sib pairs discordant for both smoking and IBD phenotype (UC or CD) to investigate whether smoking determines the type of IBD that develops in individuals with very similar genetic susceptibility. PATIENTS: Smoking habits and disease characteristics were analysed in 242 IBD pedigrees (658 patients). Within this group there were 339 affected sibling pairs of whom 89 were discordant for smoking when diagnosed. RESULTS: Smoking at diagnosis was associated with development of CD (odds ratio (OR) 3.55; 95% confidence limits 2.50-5.02; p<0.001) in all of the familial patients, with increases when analysed for ileocaecal disease, fibrostenosis, and intestinal resection. Smokers were also protected from UC (OR 0.28; 0.2-0.4; p<0.001). Of 89 sibling pairs discordant for smoking at diagnosis, 23 were also discordant for disease type-in 21 of these, CD occurred in the smoker and UC in the non-smoker (OR 10.5; 2.6-92; p<0.0001). CONCLUSIONS: Smoking is a strong environmental risk factor for Crohn's disease and increases the likelihood of needing surgery. However, sib pairs who are discordant for both smoking and IBD type almost always show CD in the smoker and UC in the non-smoker, and so in some cases tobacco consumption acts on IBD genetic predisposition to shift the phenotype from UC towards CD. The explanation of part of the apparent "protective" effect of smoking on sporadic UC may be that the form of IBD that develops in a proportion of smokers is not UC but CD.
BACKGROUND AND AIMS: Smoking tobacco has opposite effects on the different forms of inflammatory bowel disease (IBD). It predisposes to the development of Crohn's disease (CD) yet is associated with a reduced incidence of ulcerative colitis (UC). We have studied sib pairs discordant for both smoking and IBD phenotype (UC or CD) to investigate whether smoking determines the type of IBD that develops in individuals with very similar genetic susceptibility. PATIENTS: Smoking habits and disease characteristics were analysed in 242 IBD pedigrees (658 patients). Within this group there were 339 affected sibling pairs of whom 89 were discordant for smoking when diagnosed. RESULTS: Smoking at diagnosis was associated with development of CD (odds ratio (OR) 3.55; 95% confidence limits 2.50-5.02; p<0.001) in all of the familial patients, with increases when analysed for ileocaecal disease, fibrostenosis, and intestinal resection. Smokers were also protected from UC (OR 0.28; 0.2-0.4; p<0.001). Of 89 sibling pairs discordant for smoking at diagnosis, 23 were also discordant for disease type-in 21 of these, CD occurred in the smoker and UC in the non-smoker (OR 10.5; 2.6-92; p<0.0001). CONCLUSIONS: Smoking is a strong environmental risk factor for Crohn's disease and increases the likelihood of needing surgery. However, sib pairs who are discordant for both smoking and IBD type almost always show CD in the smoker and UC in the non-smoker, and so in some cases tobacco consumption acts on IBD genetic predisposition to shift the phenotype from UC towards CD. The explanation of part of the apparent "protective" effect of smoking on sporadic UC may be that the form of IBD that develops in a proportion of smokers is not UC but CD.
Authors: V Annese; A Latiano; P Bovio; P Forabosco; A Piepoli; G Lombardi; A Andreoli; M Astegiano; P Gionchetti; G Riegler; G C Sturniolo; M Clementi; E Rappaport; P Fortina; M Devoto; P Gasparini; A Andriulli Journal: Eur J Hum Genet Date: 1999-07 Impact factor: 4.246
Authors: S R Brant; Y Fu; C T Fields; R Baltazar; G Ravenhill; M R Pickles; P M Rohal; J Mann; B S Kirschner; E W Jabs; T M Bayless; S B Hanauer; J H Cho Journal: Gastroenterology Date: 1998-11 Impact factor: 22.682
Authors: J A Cavanaugh; D F Callen; S R Wilson; P M Stanford; M E Sraml; M Gorska; J Crawford; S A Whitmore; C Shlegel; S Foote; M Kohonen-Corish; P Pavli Journal: Ann Hum Genet Date: 1998-07 Impact factor: 1.670
Authors: J Hampe; S H Shaw; R Saiz; N Leysens; A Lantermann; S Mascheretti; N J Lynch; A J MacPherson; S Bridger; S van Deventer; P Stokkers; P Morin; M M Mirza; A Forbes; J E Lennard-Jones; C G Mathew; M E Curran; S Schreiber Journal: Am J Hum Genet Date: 1999-12 Impact factor: 11.025
Authors: Y Ma; J D Ohmen; Z Li; L G Bentley; C McElree; S Pressman; S R Targan; N Fischel-Ghodsian; J I Rotter; H Yang Journal: Inflamm Bowel Dis Date: 1999-11 Impact factor: 5.325
Authors: J Hampe; S Schreiber; S H Shaw; K F Lau; S Bridger; A J Macpherson; L R Cardon; H Sakul; T J Harris; A Buckler; J Hall; P Stokkers; S J van Deventer; P Nürnberg; M M Mirza; J C Lee; J E Lennard-Jones; C G Mathew; M E Curran Journal: Am J Hum Genet Date: 1999-03 Impact factor: 11.025
Authors: J H Cho; D L Nicolae; R Ramos; C T Fields; K Rabenau; S Corradino; S R Brant; R Espinosa; M LeBeau; S B Hanauer; J Bodzin; D K Bonen Journal: Hum Mol Genet Date: 2000-05-22 Impact factor: 6.150
Authors: M E Curran; K F Lau; J Hampe; S Schreiber; S Bridger; A J Macpherson; L R Cardon; H Sakul; T J Harris; P Stokkers; S J Van Deventer; M Mirza; A Raedler; W Kruis; U Meckler; D Theuer; T Herrmann; P Gionchetti; J Lee; C Mathew; J Lennard-Jones Journal: Gastroenterology Date: 1998-11 Impact factor: 22.682
Authors: Matti Waterman; Wei Xu; Joanne M Stempak; Raquel Milgrom; Charles N Bernstein; Anne M Griffiths; Gordon R Greenberg; A Hillary Steinhart; Mark S Silverberg Journal: Inflamm Bowel Dis Date: 2010-12-10 Impact factor: 5.325
Authors: Leslie M Higuchi; Hamed Khalili; Andrew T Chan; James M Richter; Athos Bousvaros; Charles S Fuchs Journal: Am J Gastroenterol Date: 2012-07-10 Impact factor: 10.864
Authors: E F Stange; S P L Travis; S Vermeire; C Beglinger; L Kupcinkas; K Geboes; A Barakauskiene; V Villanacci; A Von Herbay; B F Warren; C Gasche; H Tilg; Stefan W Schreiber; J Schölmerich; W Reinisch Journal: Gut Date: 2006-03 Impact factor: 23.059